Author | Danielle Townsley, MD | OncLive

Author | Danielle Townsley, MD


Dr. Townsley on Screening for GATA2 in At-Risk Patients for MDS, AA, and AML

May 06, 2015


Danielle Townsley, MD, staff clinician, Cell Biology Section, National Institutes of Health, discusses a study which examined screening for GATA2 in patients who are at risk for myelodysplastic syndromes (MDS), aplastic anemia (AA), and acute myeloid leukemia (AML).